Sarilumab in Rheumatoid Arthritis - COMPARE study

• Research type

  Research Study

• Full title

  A randomized, controlled study of sarilumab and methotrexate (MTX) versus etanercept and MTX in patients with rheumatoid arthritis (RA) and an inadequate response to 4 months of treatment with adalimumab and MTX

• IRAS ID

  123400

• Contact name

  Paresh Jobanputra

• Contact email

  paresh.jobanputra@uhb.nhs.uk

• Sponsor organisation

  Sanofi Aventis Recherche & Développement

• Eudract number

  2012-001984-66

• ISRCTN Number

  N/A

• Clinicaltrials.gov Identifier

  N/A

• REC name

  East Midlands - Leicester Central Research Ethics Committee

• REC reference

  13/EM/0132

• Date of REC Opinion

  10 Apr 2013

• REC opinion

  Favourable Opinion